Alexandria Real Estate Equities
ARE
#2143
Rank
HK$72.46 B
Marketcap
HK$415.81
Share price
0.30%
Change (1 day)
-28.89%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -HK$4.78 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are HK$2.85 Billion. In 2025 the company made an earning of -HK$7.77 Billion a decrease over its 2024 earnings that were of HK$5.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$4.78 Billion-38.56%
2025 -HK$7.77 Billion-242.13%
2024 HK$5.46 B96.11%
2023 HK$2.78 B-53.56%
2022 HK$5.99 B-3.96%
2021 HK$6.24 B-20.26%
2020 HK$7.83 B72.88%
2019 HK$4.53 B3.11%
2018 HK$4.39 B73.54%
2017 HK$2.53 B464.88%
2016 HK$0.44 B-77.32%
2015 HK$1.97 B36.31%
2014 HK$1.44 B-10.81%
2013 HK$1.62 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$83.07 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$244.14 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.27 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.84 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.09 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.27 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.82 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA